FDA Import Refusal AEK-2087812-9/40003/1 — Shalman Pharmaceuticals Pvt.
The FDA refused shipment AEK-2087812-9/40003/1 from Shalman Pharmaceuticals Pvt. (India) on Sep 30, 2026. The refused product falls under Drugs and Biologics — ACRIVASTINE/PSEUDOEPHEDRINE HCL (ANTI-HISTAMINIC). Cited charge: 75 This firm has 1 other import refusal on record.
Refusal Details
- Date
- Sep 30, 2026
- Country
- India
- Product Category
- Drugs and Biologics
- Product Code
- 61XDA41 ACRIVASTINE/PSEUDOEPHEDRINE HCL (ANTI-HISTAMINIC)
- Charges
- 75